The behavioral pattern is present in lean NBDs regarding the risk of developing BC: Elevated adipsin (OR: 18.5; 95%CI: 2–159.5), elevated visfatin (OR: 11.25; 95%CI: 1.3–98), and the adjusted model with elevated adipsin, adjusted for the visfatin level, represents an elevated risk of developing breast cancer, even in lean women (OR: 49.8; 95%CI: 8.2–304). This evidence concerns the gene NAMPT and breast carcinoma.